SMI
11 648,83
|
-630,65
|
-5,14%
|
Analysen zu SMI-Werten
29.03.23 | UBS Overweight | JP Morgan Chase & Co. | |
29.03.23 | Givaudan Sell | UBS AG | |
29.03.23 | Nestlé Buy | UBS AG | |
29.03.23 | UBS Buy | Goldman Sachs Group Inc. | |
29.03.23 | Roche Underweight | JP Morgan Chase & Co. | |
29.03.23 | UBS Sector Perform | RBC Capital Markets | |
28.03.23 | Novartis Neutral | UBS AG | |
28.03.23 | Givaudan Hold | Deutsche Bank AG | |
28.03.23 | Novartis Hold | Deutsche Bank AG | |
27.03.23 | Givaudan Underperform | Jefferies & Company Inc. | |
27.03.23 | Nestlé Neutral | Credit Suisse Group | |
27.03.23 | Givaudan Underweight | JP Morgan Chase & Co. | |
27.03.23 | Roche Equal Weight | Barclays Capital | |
27.03.23 | Novartis Buy | Jefferies & Company Inc. | |
24.03.23 | UBS Hold | Jefferies & Company Inc. | |
23.03.23 | ABB Outperform | RBC Capital Markets | |
23.03.23 | Richemont Overweight | JP Morgan Chase & Co. | |
21.03.23 | Swiss Re Overweight | JP Morgan Chase & Co. | |
21.03.23 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
21.03.23 | Nestlé Buy | Deutsche Bank AG | |
21.03.23 | ABB Outperform | RBC Capital Markets | |
20.03.23 | UBS Overweight | JP Morgan Chase & Co. | |
20.03.23 | UBS Outperform | RBC Capital Markets | |
20.03.23 | UBS Buy | Jefferies & Company Inc. | |
17.03.23 | Richemont Outperform | RBC Capital Markets |